Leveljump Healthcare Corp. (TSXV:JUMP)
Canada · Delayed Price · Currency is CAD 0.0550
-0.0050 (-8.33%)
At close: May 6, 2026
Leveljump Healthcare Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19.61 | 19.14 | 17.73 | 12.58 | 9.23 | 6.72 | |
Revenue Growth | 5.84% | 7.96% | 40.91% | 36.35% | 37.33% | 23.16% |
Cost of Revenue | 14.89 | 13.94 | 13.18 | 9.71 | 7.37 | 5.37 |
Gross Profit | 4.72 | 5.2 | 4.55 | 2.87 | 1.86 | 1.35 |
Selling, General & Admin | 0.94 | 1.09 | 0.95 | 1.02 | 1.96 | 2.77 |
Amortization of Goodwill & Intangibles | 0.49 | 0.49 | 0.49 | 0.26 | 0.11 | - |
Other Operating Expenses | 3.06 | 2.56 | 2.01 | 2.08 | - | - |
Operating Expenses | 5.37 | 5.13 | 4.61 | 3.69 | 2.54 | 3.55 |
Operating Income | -0.65 | 0.06 | -0.06 | -0.82 | -0.68 | -2.2 |
Interest Expense | -1.06 | -1 | -1.07 | -0.4 | -0.14 | -0.04 |
Currency Exchange Gain (Loss) | -0 | -0 | -0.01 | -0 | -0 | 0 |
Other Non Operating Income (Expenses) | -0.12 | 0.12 | 0.06 | -0.11 | -0.02 | 0.04 |
EBT Excluding Unusual Items | -1.83 | -0.82 | -1.08 | -1.34 | -0.85 | -2.2 |
Gain (Loss) on Sale of Investments | - | - | 0.1 | -1.09 | - | - |
Gain (Loss) on Sale of Assets | - | - | -0.04 | -0.02 | -0 | - |
Other Unusual Items | - | - | - | - | 1.04 | -0.03 |
Pretax Income | -1.83 | -0.82 | -1.03 | -2.44 | 0.19 | -2.23 |
Income Tax Expense | 2.29 | 2.27 | -2.19 | -0.24 | - | - |
Net Income | -4.12 | -3.09 | 1.16 | -2.21 | 0.19 | -2.23 |
Net Income to Common | -4.12 | -3.09 | 1.16 | -2.21 | 0.19 | -2.23 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 99 | 96 | 96 | 92 | 79 | 48 |
Shares Outstanding (Diluted) | 99 | 96 | 110 | 92 | 79 | 48 |
Shares Change | -9.52% | -12.23% | 19.71% | 15.86% | 66.18% | 1697.13% |
EPS (Basic) | -0.04 | -0.03 | 0.01 | -0.02 | 0.00 | -0.05 |
EPS (Diluted) | -0.04 | -0.03 | 0.01 | -0.02 | 0.00 | -0.05 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.75 | 1.37 | 0.72 | -1.05 | -0.03 | -1.79 |
Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | -0.01 | - | -0.04 |
Gross Margin | 24.06% | 27.16% | 25.64% | 22.81% | 20.14% | 20.12% |
Operating Margin | -3.32% | 0.33% | -0.37% | -6.54% | -7.41% | -32.70% |
Profit Margin | -21.03% | -16.13% | 6.55% | -17.55% | 2.00% | -33.17% |
Free Cash Flow Margin | 3.83% | 7.17% | 4.05% | -8.32% | -0.32% | -26.66% |
EBITDA | 0.15 | 0.97 | 0.86 | -0.57 | -0.57 | -2.2 |
EBITDA Margin | 0.75% | 5.05% | 4.85% | -4.50% | -6.19% | -32.68% |
D&A For EBITDA | 0.8 | 0.9 | 0.93 | 0.26 | 0.11 | 0 |
EBIT | -0.65 | 0.06 | -0.06 | -0.82 | -0.68 | -2.2 |
EBIT Margin | -3.32% | 0.33% | -0.37% | -6.54% | -7.41% | -32.70% |
Revenue as Reported | - | - | - | - | 9.23 | 6.72 |
Advertising Expenses | - | 0.05 | 0.04 | 0.03 | - | 0.68 |